Name Funds holding
in top 10
Growth Growth % Return since
30 Sep ‘13
576
16 +2 +14% 315%
577
8 +1 +14% 49.9%
578
8 +1 +14% 260%
SRE icon
579
Sempra
SRE
$58.2B
8 +1 +14% 108%
580
8 +1 +14% 0.6%
581
8 +1 +14% 57.9%
582
8 +1 +14% 326%
583
8 +1 +14% 52.3%
584
8 +1 +14% 106%
585
8 +1 +14% 22.1%
ACAD icon
586
Acadia Pharmaceuticals
ACAD
$4.5B
8 +1 +14% 3.2%
587
8 +1 +14% 1,354%
588
8 +1 +14% 52.6%
589
8 +1 +14% 687%
590
8 +1 +14% 76.4%
591
8 +1 +14% 76.5%
592
8 +1 +14% 126%
593
8 +1 +14% 30.9%
594
8 +1 +14% 757%
595
25 +3 +14% 238%
596
76 +9 +13% 64%
597
18 +2 +13% 355%
598
9 +1 +13% 2.44%
599
9 +1 +13% 12.8%
600
9 +1 +13% 190%